Home  /  Resource Library  /  Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first‐line treatment of primary mediastinal B-cell lymphoma

Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first‐line treatment of primary mediastinal B-cell lymphoma

Results of a study comparing two rituximab based chemoimmunotherapy combinations for first line treatment of PMBCL.